Logo image of LVRO

LAVORO LTD-CL A (LVRO) Stock Fundamental Analysis

NASDAQ:LVRO - Nasdaq - KYG5391L1023 - Common Stock - Currency: USD

3.0553  -0.02 (-0.63%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to LVRO. LVRO was compared to 48 industry peers in the Trading Companies & Distributors industry. LVRO may be in some trouble as it scores bad on both profitability and health. LVRO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

LVRO had negative earnings in the past year.
In the past year LVRO had a positive cash flow from operations.
In multiple years LVRO reported negative net income over the last 5 years.
LVRO had negative operating cash flow in 4 of the past 5 years.
LVRO Yearly Net Income VS EBIT VS OCF VS FCFLVRO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 100M -100M 200M -200M

1.2 Ratios

The Return On Assets of LVRO (-5.20%) is worse than 89.58% of its industry peers.
Looking at the Return On Equity, with a value of -30.98%, LVRO is doing worse than 91.67% of the companies in the same industry.
Industry RankSector Rank
ROA -5.2%
ROE -30.98%
ROIC N/A
ROA(3y)1.3%
ROA(5y)N/A
ROE(3y)-2.01%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LVRO Yearly ROA, ROE, ROICLVRO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 5 -5 -10

1.3 Margins

LVRO has a worse Gross Margin (15.20%) than 91.67% of its industry peers.
The Profit Margin and Operating Margin are not available for LVRO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 15.2%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LVRO Yearly Profit, Operating, Gross MarginsLVRO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 5 10 15

More info and screens

3

2. Health

2.1 Basic Checks

LVRO does not have a ROIC to compare to the WACC, probably because it is not profitable.
LVRO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LVRO Yearly Shares OutstandingLVRO Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 20M 40M 60M 80M 100M
LVRO Yearly Total Debt VS Total AssetsLVRO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2B 4B 6B

2.2 Solvency

LVRO has an Altman-Z score of 1.01. This is a bad value and indicates that LVRO is not financially healthy and even has some risk of bankruptcy.
LVRO has a Altman-Z score of 1.01. This is amonst the worse of the industry: LVRO underperforms 83.33% of its industry peers.
The Debt to FCF ratio of LVRO is 18.18, which is on the high side as it means it would take LVRO, 18.18 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of LVRO (18.18) is comparable to the rest of the industry.
LVRO has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
LVRO's Debt to Equity ratio of 0.08 is amongst the best of the industry. LVRO outperforms 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 18.18
Altman-Z 1.01
ROIC/WACCN/A
WACC19.87%
LVRO Yearly LT Debt VS Equity VS FCFLVRO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.05 indicates that LVRO should not have too much problems paying its short term obligations.
With a Current ratio value of 1.05, LVRO is not doing good in the industry: 85.42% of the companies in the same industry are doing better.
LVRO has a Quick Ratio of 1.05. This is a bad value and indicates that LVRO is not financially healthy enough and could expect problems in meeting its short term obligations.
LVRO's Quick ratio of 0.71 is on the low side compared to the rest of the industry. LVRO is outperformed by 72.92% of its industry peers.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 0.71
LVRO Yearly Current Assets VS Current LiabilitesLVRO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 1B 2B 3B 4B 5B

More info and screens

1

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-425%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-23.37%

3.2 Future

The Earnings Per Share is expected to grow by 23.18% on average over the next years. This is a very strong growth
Based on estimates for the next years, LVRO will show a decrease in Revenue. The Revenue will decrease by -5.92% on average per year.
EPS Next Y22.48%
EPS Next 2Y26.31%
EPS Next 3Y23.18%
EPS Next 5YN/A
Revenue Next Year-31.48%
Revenue Next 2Y-11.87%
Revenue Next 3Y-5.92%
Revenue Next 5YN/A

3.3 Evolution

LVRO Yearly Revenue VS EstimatesLVRO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2B 4B 6B 8B
LVRO Yearly EPS VS EstimatesLVRO Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LVRO. In the last year negative earnings were reported.
Also next year LVRO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LVRO Price Earnings VS Forward Price EarningsLVRO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

66.67% of the companies in the same industry are more expensive than LVRO, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 20.64
EV/EBITDA N/A
LVRO Per share dataLVRO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

A more expensive valuation may be justified as LVRO's earnings are expected to grow with 23.18% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.31%
EPS Next 3Y23.18%

More info and screens

0

5. Dividend

5.1 Amount

LVRO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LAVORO LTD-CL A

NASDAQ:LVRO (4/22/2025, 4:30:00 PM)

3.0553

-0.02 (-0.63%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)04-14 2025-04-14/amc
Earnings (Next)N/A N/A
Inst Owners87.67%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap357.44M
Analysts84.44
Price Target5.61 (83.62%)
Short Float %0.06%
Short Ratio6.85
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-8.91%
Min EPS beat(2)-50.98%
Max EPS beat(2)33.15%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)15.29%
Min Revenue beat(2)-10.25%
Max Revenue beat(2)40.83%
Revenue beat(4)1
Avg Revenue beat(4)-10.52%
Min Revenue beat(4)-44.35%
Max Revenue beat(4)40.83%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-9.59%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.23
P/FCF 20.64
P/OCF 11.33
P/B 1.18
P/tB 2.63
EV/EBITDA N/A
EPS(TTM)-0.27
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)0.15
FCFY4.84%
OCF(TTM)0.27
OCFY8.83%
SpS13.48
BVpS2.59
TBVpS1.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.2%
ROE -30.98%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 15.2%
FCFM 1.1%
ROA(3y)1.3%
ROA(5y)N/A
ROE(3y)-2.01%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 18.18
Debt/EBITDA N/A
Cap/Depr 53.41%
Cap/Sales 0.9%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 0.71
Altman-Z 1.01
F-Score4
WACC19.87%
ROIC/WACCN/A
Cap/Depr(3y)50.72%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-425%
EPS Next Y22.48%
EPS Next 2Y26.31%
EPS Next 3Y23.18%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-23.37%
Revenue Next Year-31.48%
Revenue Next 2Y-11.87%
Revenue Next 3Y-5.92%
Revenue Next 5YN/A
EBIT growth 1Y-136.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-60.95%
EBIT Next 3Y-11.95%
EBIT Next 5Y-5.75%
FCF growth 1Y9212.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y16704.5%
OCF growth 3YN/A
OCF growth 5YN/A